Harrow Health Inc.

NASDAQ: HROW · Real-Time Price · USD
38.80
-1.21 (-3.02%)
At close: Aug 15, 2025, 3:45 PM
40.60
1.34%
Pre-market: Aug 15, 2025, 09:28 AM EDT

Harrow Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
227.66M 212.86M 199.61M 169.14M 154.15M 138.68M 130.19M 114.17M 102.72M 92.58M 88.59M 88.45M 84.34M 79.15M 72.48M 66.88M 62.57M 52.5M
Cost of Revenue
57.91M 54.22M 49.24M 46.41M 44.46M 41.92M 39.64M 34.5M 31.16M 27.69M 25.38M 24.3M 22.52M 20.41M 18.21M 17.07M 15.82M 14.61M
Gross Profit
169.75M 158.64M 150.37M 122.73M 109.69M 96.75M 90.55M 79.66M 71.57M 64.89M 63.21M 64.16M 61.82M 58.75M 54.26M 49.81M 46.75M 37.89M
Operating Income
14.4M 4.52M 8.82M -8.95M -8.53M -7.71M 431K 3.53M 1.69M 1.03M 1.92M 1.94M -1.68M 798K 1.61M 6M 11.31M 3.93M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 1.86M 1.86M 1.86M 1.86M n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-10.72M -21.54M -17.32M -33.27M -31.92M -30.34M -23.71M -12.97M -16.55M -18.5M -14.01M -22.35M -24.25M -20.53M -17.87M -9.44M 7.51M 9.72M
Net Income
-10.23M -21.7M -17.48M -33.41M -33.58M -31.33M -24.41M -14.21M -16.28M -18.29M -14.09M -22.56M -24.42M -20.66M -18.01M -9.44M 7.53M 9.77M
Selling & General & Admin
142.18M 140.76M 129.06M 120.49M 107.88M 96.02M 83.09M 72.12M 66.5M 60.73M 58.24M 55.68M 51.61M 46.55M 41.31M 36.08M 33.16M 31M
Research & Development
12.92M 13.11M 12.23M 10.81M 9.96M 8.07M 6.65M 4.02M 3.37M 3.13M 3.05M 6.29M 11.64M 11.15M 11.08M 7.73M 2.28M 2.6M
Other Expenses
253K 253K 253K 380K 380K 380K 380K n/a n/a n/a n/a 249K 249K 198K 198K -51K -46K 24K
Operating Expenses
155.36M 154.12M 141.55M 131.68M 118.21M 104.46M 90.12M 76.14M 69.88M 63.86M 61.29M 61.97M 63.25M 57.7M 52.4M 43.82M 35.44M 33.6M
Interest Expense
12.04M 23.92M 22.79M 21.54M 21.76M 21.99M 21.32M 21.64M 17.7M 13.79M 10.83M 7.31M 7.2M 6.71M 5.44M 5.3M 4.11M 3.3M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 7.41M 7.41M 7.41M
Cost & Expenses
213.26M 208.34M 190.79M 178.09M 162.68M 146.38M 129.76M 110.64M 101.03M 91.55M 86.68M 86.51M 86.02M 78.36M 70.86M 60.89M 51.26M 48.57M
Income Tax Expense
-494K 161K 161K 140K 1.66M 989K 701K 1.24M -268K -213K 75K 208K 173K 133K 133K 4K 4K 4K
Shares Outstanding (Basic)
36.79M 35.83M 35.81M 35.7M 35.62M 35.47M 35.35M 34.26M 30.46M 30.29M 27.96M 27.35M 27.3M 27.09M 27.47M 27.11M 26.74M 26.02M
Shares Outstanding (Diluted)
38.85M 35.83M 35.81M 35.7M 35.62M 35.47M 35.35M 34.26M 30.46M 30.29M 29.43M 27.35M 27.3M 27.23M 27.47M 27.11M 26.74M 27.48M
EPS (Basic)
-0.29 -0.61 -0.49 -0.94 -0.95 -0.91 -0.75 -0.45 -0.56 -0.65 -0.52 -0.83 -0.9 -0.78 -0.68 -0.37 0.27 0.37
EPS (Diluted)
-0.3 -0.61 -0.49 -0.94 -0.95 -0.91 -0.75 -0.45 -0.56 -0.65 -0.52 -0.83 -0.9 -0.78 -0.68 -0.37 0.26 0.36
EBITDA
27.2M 18.65M 20M 878K 2.28M 4.3M 9.77M 15.3M 5.41M -2.91M -3.1M 2.56M 296K 3.18M 4.26M -2.75M 13.16M 14.65M
EBIT
2.73M 2.38M 5.47M -11.73M -10.16M -8.35M -2.39M 5.09M -2.44M -8.3M -6.77M -740K -2.75M 487K 1.86M -3.33M 12.43M 13.84M
Depreciation & Amortization
13.06M 16.27M 14.54M 12.61M 12.44M 12.66M 12.15M 10.21M 7.85M 5.39M 3.5M 3.04M 2.79M 2.43M 2.3M 2.51M 2.65M 2.73M